Patents by Inventor John Denick, Jr.

John Denick, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120028947
    Abstract: An aqueous ophthalmic composition comprising loteprednol etabonate, and polyacryclic acid. The composition has a viscosity in the range from about 300 cp to about 1500 cp, and a total concentration of cations of less than about 50 mM. The ophthalmic composition is used to treat patients suffering from allergic conjunctivitis, and includes instructing a person suffering from ocular itching resulting from allergic conjunctivitis to administer once or twice daily in the form of one or more eye drops the aqueous ophthalmic composition described.
    Type: Application
    Filed: September 22, 2011
    Publication date: February 2, 2012
    Inventors: Erning Xia, John Denick, JR., Judith K. Denick, Richard V. Smerbeck, Martin J. Coffey
  • Publication number: 20100234336
    Abstract: An aqueous ophthalmic composition comprises a carboxy-containing polyanionic polymer that has a viscosity in the range from about 300 cp to about 1500 cp outside the eye and a total concentration of cations of less than about 50 mM, wherein the viscosity of the composition does not increase when the composition comes into contact with surface ocular fluid.
    Type: Application
    Filed: March 26, 2010
    Publication date: September 16, 2010
    Inventors: Erning Xia, John Denick, JR., Richard V. Smerbeck, Martin J. Coffey
  • Patent number: 6514528
    Abstract: The invention provides a method for inhibiting the binding of a biguanide disinfectant in aqueous solution to a poly(ethylene) solid in contact with said solution comprising providing in said solution an amount of cyclodextrin sufficient to inhibit binding of the biguanide disinfectant to the poly(ethylene) solid.
    Type: Grant
    Filed: July 27, 2001
    Date of Patent: February 4, 2003
    Assignee: Bausch & Lomb Incorporated
    Inventors: Erning Xia, Richard V. Smerbeck, John Denick, Jr.
  • Patent number: 6348507
    Abstract: The present invention provides an optically clear, hydrophilic coating upon the surface of a silicone hydrogel lens by plasma treating the lens and subsequently heating the lens in an aqueous solution containing a surface-protective agent.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: February 19, 2002
    Assignee: Bausch & Lomb Incorporated
    Inventors: David J. Heiler, Suzanne F. Groemminger, John Denick, Jr., Lisa C. Simpson
  • Patent number: 6348508
    Abstract: The present invention is directed to a method of treating dry eye by instilling eyedrops of a composition containing a cationic cellulosic polymer. Such compositions have been found to alleviate the symptoms of dry eye without requiring the presence of anionic therapeutic agents. Low ionic strength solutions are particularly preferred.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: February 19, 2002
    Assignee: Bausch & Lomb Incorporated
    Inventors: John Denick, Jr., David J. Heiler, Zhenze Hu, Joseph C. Salamone, Richard V. Smerbeck
  • Patent number: 6309658
    Abstract: The present invention provides methods and compositions for cleaning and disinfecting contact lenses, which compositions comprise a carbonate or bicarbonate salt, a non-carbonate buffer system, an antimicrobial agent, and a non-ionic surfactant. Products according to the present invention, especially multi-purpose solutions, provide simultaneous disinfection and cleaning of contact lenses including the prevention or removal of protein and lipid deposits and other debris.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: October 30, 2001
    Assignee: Bausch & Lomb Incorporated
    Inventors: Erning Xia, Lisa C. Simpson, John Denick, Jr.
  • Patent number: 6037328
    Abstract: The present invention is directed to an ophthalmic solution for the treatment of contact lenses while worn in the eye. In particular, the composition contains ethoxylated glucose derivative, tyloxapol, and a polyoxyethylene-polyoxypropylene nonionic surfactant. The ophthalmic solution containing such a combination of components can be applied, in the form of drops, to the eye or to contact lens in the eye. In one embodiment of the invention, the composition is used for reducing unwanted lipid or protein deposition on extended-wear lenses, including lenses made from relatively hydrophobic materials such as silicon hydrogels.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: March 14, 2000
    Assignee: Bausch & Lomb Incorporated
    Inventors: Zhenze Hu, Edward J. Ellis, John Denick, Jr.
  • Patent number: 5681577
    Abstract: A chewable cold/sinus preparation comprising a bitter tasting mixture of a decongestant such as pseudoephedrine and an antihistamine such as diphenhydramine and/or chlorpheniramine maleate is made with no bitter, metallic taste or unpleasant mouthfeel by adsorbing the active drug mixture using a wet granulation process onto a silicon dioxide carrier which comprises from about 50 to about 85% of total weight of the adsorbate composition. A truly multi-symptom relief formula is prepared through the optional addition of an antitussive such as dextromethorphan hydrobromide and/or an analgesic such as meclofenamic acid, aspirin or ibuprofen. Additional excipients such as flavors, sweeteners, lubricants and bulk fillers are added for better taste, improved mouthfeel and as an aid to the tabletting process.
    Type: Grant
    Filed: September 19, 1995
    Date of Patent: October 28, 1997
    Assignee: Warner-Lambert Company
    Inventors: Stanley Lech, Alexander M. Schobel, John Denick, Jr.
  • Patent number: 5641513
    Abstract: A method for coating pharmaceutical tablets is disclosed in which polymeric coating ingredients are combined with saccharides in a melt spinning operation to form composite particulates. The particulates are then dispersed in water to form an aqueous polymer coating solution, followed by application to pharmaceutical tablets by such methods as spray coating. The particulates dissolve extremely rapidly in water to form a dispersion of the polymer coating ingredients. Such rapid dissolution allows for increased processing rates and avoids disadvantages of the prior art such as the requirement of high sheer rate mixing for long times.
    Type: Grant
    Filed: October 17, 1995
    Date of Patent: June 24, 1997
    Assignee: Warner-Lambert Company
    Inventors: Stanley Lech, John Denick, Jr.
  • Patent number: 5641536
    Abstract: A method for coating pharmaceutical tablets is disclosed in which polymeric coating ingredients are combined with saccharides in a melt spinning operation to form composite particulates. The particulates are then dispersed in water to form an aqueous polymer coating solution, followed by application to pharmaceutical tablets by such methods as spray coating. The particulates dissolve extremely rapidly in water to form a dispersion of the polymer coating ingredients. Such rapid dissolution allows for increased processing rates and avoids disadvantages of the prior art such as the requirement of high shear rate mixing for long times.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 24, 1997
    Assignee: Warner-Lambert Company
    Inventors: Stanley Lech, John Denick, Jr.
  • Patent number: 4978529
    Abstract: Powdered psyllium seek husks are rendered rapidly and uniformly dispersible in water by admixing a solvent selected from the group consisting of benzyl alcohol, propylene glycol, triacetin and mixtures thereof with powdered psyllium seed husks.
    Type: Grant
    Filed: May 25, 1988
    Date of Patent: December 18, 1990
    Inventor: John Denick, Jr.
  • Patent number: 4761274
    Abstract: A medicament adsorbate of analgesics and process for making same. The medicament adsorbate comprises a complex magnesium aluminum silicate having sorbed therein an analgesic. The complex magnesium aluminum silicate has the following typical chemical analysis:______________________________________ Ratio to Percent by Weight Aluminum Oxide ______________________________________ Silicon dioxide 56 to 59 14.0 to 29.5 Magnesium oxide 21 to 24 5.2 to 12.0 Aluminum oxide 2.0 to 4.0 1 Ferric oxide 0.4 to 0.6 Calcium oxide 1.1 to 1.5 Sodium oxide 2.5 to 3.5 Potassium oxide 0.5 to 1.0 Ignition Loss 5.5 to 12.
    Type: Grant
    Filed: October 16, 1987
    Date of Patent: August 2, 1988
    Assignee: Warner-Lambert Company
    Inventors: John Denick, Jr., David Peters, Anil K. Talwar, Wei C. Liao
  • Patent number: 4758425
    Abstract: A medicament adsorbate of antiasthmatics and process for making same. The medicament adsorbate comprises a complex magnesium aluminum silicate having sorbed therein an antiasthmatic. The complex magnesium aluminum silicate has the following typical chemical analysis:______________________________________ Ratio to Percent by Weight Aluminum Oxide ______________________________________ Silicon dioxide 56 to 59 14.0 to 29.5 Magnesium oxide 21 to 24 5.2 to 12.0 Aluminum oxide 2.0 to 4.0 1 Ferric oxide 0.4 to 0.6 Calcium oxide 1.1 to 1.5 Sodium oxide 2.5 to 3.5 Potassium oxide 0.5 to 1.0 Ignition Loss 5.5 to 12.
    Type: Grant
    Filed: October 16, 1987
    Date of Patent: July 19, 1988
    Assignee: Warner-Lambert Company
    Inventors: John Denick, Jr., David Peters, Anil K. Talwar, Wei C. Liao
  • Patent number: 4758424
    Abstract: A medicament adsorbate of decongestants and process for making same. The medicament adsorbate comprises a complex magnesium aluminum silicate having sorbed therein a decongestant. The complex magnesium aluminum silicate has the following typical chemical analysis:______________________________________ Ratio to Percent by Weight Aluminum Oxide ______________________________________ Silicon dioxide 56 to 59 14.0 to 29.5 Magnesium oxide 21 to 24 5.2 to 12.0 Aluminum oxide 2.0 to 4.0 1 Ferric oxide 0.4 to 0.6 Calcium oxide 1.1 to 1.5 Sodium oxide 2.5 to 3.5 Potassium oxide 0.5 to 1.0 Ignition Loss 5.5 to 12.
    Type: Grant
    Filed: October 16, 1987
    Date of Patent: July 19, 1988
    Assignee: Warner-Lambert Company
    Inventors: John Denick, Jr., David Peters, Anil K. Talwar, Wei C. Liao
  • Patent number: 4717565
    Abstract: A process for preparing a medicament adsorbate by sorbing a medicament drug onto a swollen hydrated complex magnesium aluminum silicate and drying the swollen mass to a final solvent content of up to about 20% by weight of the medicament adsorbate.
    Type: Grant
    Filed: March 27, 1986
    Date of Patent: January 5, 1988
    Assignee: Warner-Lambert Company
    Inventor: John Denick, Jr.
  • Patent number: 4716033
    Abstract: A medicament adsorbate and process for making same. The medicament adsorbate comprises a complex magnesium aluminum, silicate having sorbed therein a medicament drug and a surfactant.
    Type: Grant
    Filed: March 27, 1986
    Date of Patent: December 29, 1987
    Assignee: Warner-Lambert Company
    Inventor: John Denick, Jr.
  • Patent number: 4711774
    Abstract: A medicament adsorbate and process for making same. The medicament adsorbate comprises a complex magnesium aluminum silicate having sorbed therein a medicament drug. The complex magnesium aluminum silicate has the following typical chemical analysis:______________________________________ Ratio to Percent by Weight Aluminum Oxide ______________________________________ Silicon dioxide 56 to 59 14.0 to 29.5 Magnesium oxide 21 to 24 5.2 to 12.0 Aluminum oxide 2.0 to 4.0 1 Ferric oxide 0.4 to 0.6 Calcium oxide 1.1 to 1.5 Sodium oxide 2.5 to 3.5 Potassium oxide 0.5 to 1.0 Ignition Loss 5.5 to 12.
    Type: Grant
    Filed: March 27, 1986
    Date of Patent: December 8, 1987
    Assignee: Warner-Lambert Company
    Inventors: John Denick, Jr., David Peters, Anil K. Talwar, Wei C. Liao
  • Patent number: 4650663
    Abstract: A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m.sup.2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the adsorbate of a medicament drug, wherein the medicament drug is an antitussive.
    Type: Grant
    Filed: December 19, 1985
    Date of Patent: March 17, 1987
    Assignee: Warner-Lambert Company
    Inventors: David Peters, John Denick, Jr., Anil K. Talwar
  • Patent number: 4649041
    Abstract: A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m.sup.2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the adsorbate of a medicament drug, wherein the medicament drug is an antinauseant.
    Type: Grant
    Filed: December 19, 1985
    Date of Patent: March 10, 1987
    Assignee: Warner-Lambert Company
    Inventors: David Peters, John Denick, Jr., Anil K. Talwar
  • Patent number: 4647450
    Abstract: A chewing gum composition containing a magnesium trisilicate having a surface area of at least 400 m.sup.2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the adsorbate of a medicament drug. Such compositions may be in the form of sticks, slabs, chunks, balls, ropes, shredded tablets and/or center filled.
    Type: Grant
    Filed: December 19, 1985
    Date of Patent: March 3, 1987
    Assignee: Warner-Lambert Company
    Inventors: David Peters, John Denick, Jr., Anil K. Talwar